Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07277088

The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy

A Prospective, Single-center, Randomized Controlled Clinical Study to Evaluate the Efficacy and Safety of the Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
158 (estimated)
Sponsor
Jiayuan Sun · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This prospective, single-center, non-inferiority, randomized controlled clinical trial aims to evaluate the efficacy and safety of a percutaneous interventional surgical control system in performing percutaneous needle biopsy of pulmonary nodules, compared with conventional manual biopsy. The study will be conducted at Shanghai Chest Hospital and plans to enroll 158 patients who meet the indications for percutaneous transthoracic needle biopsy (PTNB) and have no contraindications. Participants will be randomly assigned to one of two groups: the experimental group will undergo PTNB assisted by the percutaneous interventional surgical control system, while the control group will receive traditional manual PTNB. The primary endpoint is diagnostic yield; secondary endpoints include technical success rate, number of needle adjustments, puncture time, total procedure time, radiation dose, and complication rates.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPercutaneous Needle Biopsy with Interventional Surgical Control SystemPatients undergo percutaneous needle biopsy of pulmonary nodules with assistance from a percutaneous interventional surgical control system. The system performs automatically needle positioning and puncture.
DIAGNOSTIC_TESTConventional Manual Percutaneous Needle BiopsyPatients receive traditional manual percutaneous needle biopsy of pulmonary nodules under CT guidance, operated by experienced interventional physicians.

Timeline

Start date
2025-12-10
Primary completion
2027-05-30
Completion
2027-05-30
First posted
2025-12-11
Last updated
2025-12-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07277088. Inclusion in this directory is not an endorsement.